INS and polycystic ovary syndrome: Metformin, a biguanide that decreases hepatic glucose production and increases body insulin sensitivity, is recommended in the 2018 international evidence-based PCOS guideline (5) for management of anthropometric and metabolic outcomes in PCOS.